Germline Variation Predicts Treatment Response in Multiple Myeloma von Roter, Kyle, Hu, Donglei, Clay-Gilmour, Alyssa, Huntsman, Scott, Shah, Nina D., Wong, Sandy W., Martin, Thomas G., Wolf, Jeffrey Lee, Binder, Moritz, Kumar, Shaji K., Rajkumar, S. Vincent, Slager, Susan L., Vachon, Celine M., Ziv, Elad

Volltext

Testing a best practices risk result format to communicate genetic risks von Davis, Kyle W., Roter, Debra L., Schmidlen, Tara, Scheinfeldt, Laura B., Klein, William M.P.

Volltext

Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action von Ganter, Brigitte, Tugendreich, Stuart, Pearson, Cecelia I., Ayanoglu, Eser, Baumhueter, Susanne, Bostian, Keith A., Brady, Lindsay, Browne, Leslie J., Calvin, John T., Day, Gwo-Jen, Breckenridge, Naiomi, Dunlea, Shane, Eynon, Barrett P., Furness, L. Mike, Ferng, Joe, Fielden, Mark R., Fujimoto, Susan Y., Gong, Li, Hu, Christopher, Idury, Radha, Judo, Michael S.B., Kolaja, Kyle L., Lee, May D., McSorley, Christopher, Minor, James M., Nair, Ramesh V., Natsoulis, Georges, Nguyen, Peter, Nicholson, Simone M., Pham, Hang, Roter, Alan H., Sun, Dongxu, Tan, Siqi, Thode, Silke, Tolley, Alexander M., Vladimirova, Antoaneta, Yang, Jian, Zhou, Zhiming, Jarnagin, Kurt

Volltext

308 Drugmatrix™ provides predictive chemogenomics solutions for safety assessment in drug discovery and development von Gee, Pauline, Mitchell, Richard, Browne, Leslie, Kolaja, Kyle, Jarnagin, Kurt, Natsoulis, George, Roter, Alan

Volltext